BS
Baljinder Singh
AstraZeneca Oncology R&D, Northeastern University, Indian Institute of Integrative Medicine CSIR, National Institute of Pharmaceutical Education and Research Ahmedabad
0000-0003-2828-5768
Employment
-
AstraZeneca Oncology R&D Senior Scientist Medicinal Chemistry2021 - Present
-
Northeastern University Senior Research Scientist2015 - 2021
-
Indian Institute of Integrative Medicine CSIR Research Associate2010 - 2015
-
Piramal Life Sciences Ltd Research Associate2009 - 2010
Education
-
Indian Institute of Integrative Medicine CSIR PhD2010 - 2015
-
National Institute of Pharmaceutical Education and Research Ahmedabad M. S. Pharm2007 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (29)
- Optimization of Quinazolines for Inhibition of Trypanosoma brucei Proliferation Save
- Green synthesis and biological evaluation of glaucanic acid and dihydrocompactin acid by endophytic fungus Penicillium polonicum from Zingiber officinal e Save
- Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery Save
- Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for Trypanosoma brucei Inhibitors Save
- Scaffold and Parasite Hopping: Discovery of New Protozoal Proliferation Inhibitors Save
- Structure–Bioactivity Relationships of Lapatinib Derived Analogs against Schistosoma mansoni Save
- Improvement of Aqueous Solubility of Lapatinib-Derived Analogues: Identification of a Quinolinimine Lead for Human African Trypanosomiasis Drug Development Save
- Series of Alkynyl-Substituted Thienopyrimidines as Inhibitors of Protozoan Parasite Proliferation Save
- A novel colchicine-based microtubule inhibitor exhibits potent antitumor activity by inducing mitochondrial mediated apoptosis in MIA PaCa-2 pancreatic cancer cells Save
- A novel microtubule depolymerizing colchicine analogue triggers apoptosis and autophagy in HCT-116 colon cancer cells Save